Castle Biosciences Inc (CSTL) - Gunggung Aset Perusahaan

Castle Biosciences (CSTL) has established a unique network in dermato-oncology, where its analytical solutions have become the baseline standard of therapy. The company is implementing artificial intelligence algorithms to decode tumor genetics, enabling the containment of the disease at early stages. Financial stability is supported by insurance payouts, and total assets reach 552.99. The price action chart below illustrates the dynamics of these indicators.

This indicator mathematically reconstructs the issuer's total resource value through a reverse calculation of return on assets (ROA), transforming static balance sheet data into a dynamic curve to filter out market noise. By analyzing the total asset value, the investor can see the actual scale of capitalization for Castle Biosciences (CSTL), which directly depends on the volume of contracts with oncology centers for the supply of high-precision diagnostic systems.